scholarly journals Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies

CNS Drugs ◽  
2021 ◽  
Author(s):  
Richard L. Doty ◽  
Vanina Popova ◽  
Crystal Wylie ◽  
Maggie Fedgchin ◽  
Ella Daly ◽  
...  
Keyword(s):  
Nasal Spray ◽  
Olfactory Function ◽  
Phase Iii ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Resistant Depression ◽  
Phase Iii Studies

scholarly journals Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial

The Lancet ◽  
2015 ◽  
Vol 386 (10011) ◽  
pp. 2404-2412 ◽  
Author(s):  
Eric J Lenze ◽  
Benoit H Mulsant ◽  
Daniel M Blumberger ◽  
Jordan F Karp ◽  
John W Newcomer ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Late Life ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Resistant Depression

scholarly journals Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

2018 ◽  
Vol 25 (7) ◽  
pp. 1592-1603 ◽  
Author(s):  
Maurizio Fava ◽  
Marlene P. Freeman ◽  
Martina Flynn ◽  
Heidi Judge ◽  
Bettina B. Hoeppner ◽  
...  
Keyword(s):  
Adjunctive Therapy ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dose Ranging ◽  
Resistant Depression ◽  
Intravenous Ketamine
Sign in / Sign up

Export Citation Format

Share Document